Dabomb Protein Biotech (ROCO:6578) Shares Outstanding (EOP): 71.9 Mil (As of Dec. 2025)


ROCO:6578 Dabomb Protein Biotech Corp ROCO:6578
59 GF Score
Price NT$16.40
GF Value NT$14.52
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Dabomb Protein Biotech Shares Outstanding (EOP)?

Dabomb Protein Biotech ROCO:6578 59 Shares Outstanding (EOP) is 71.9 Mil as of Dec. 2025. GuruFocus rates ROCO:6578 with a GF Score™ of 59/100 and a GF Value™ of NT$14.52 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Dabomb Protein Biotech's shares outstanding for the quarter that ended in Dec. 2025 was 71.9 Mil.

Dabomb Protein Biotech's quarterly shares outstanding stayed the same from Sep. 2025 (71.9 Mil) to Dec. 2025 (71.9 Mil).

Dabomb Protein Biotech's annual shares outstanding increased from Dec. 2024 (68.0 Mil) to Dec. 2025 (71.9 Mil). It means Dabomb Protein Biotech issued new shares from Dec. 2024 to Dec. 2025 .


Dabomb Protein Biotech  (ROCO:6578) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Dabomb Protein Biotech Shares Outstanding (EOP) Related Terms


Dabomb Protein Biotech Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Dabomb Protein Biotech's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech Shares Outstanding (EOP) Chart

Dabomb Protein Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.08 39.51 59.71 67.99 71.94

Dabomb Protein Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.99 71.94 71.94 71.94 71.94

ROCO:6578 vs KHC, GIS: Shares Outstanding (EOP) Comparison

For the Packaged Foods subindustry, Dabomb Protein Biotech's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dabomb Protein Biotech Shares Outstanding (EOP) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Dabomb Protein Biotech's Shares Outstanding (EOP) falls into.


ROCO:6578
59GF Score
Dabomb Protein Biotech Corp ROCO:6578
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dabomb Protein Biotech Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 71.9 Mil mean?
Dabomb Protein Biotech (ROCO:6578) has a Shares Outstanding (EOP) of 71.9 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Dabomb Protein Biotech and its competitors.
Is Dabomb Protein Biotech's Shares Outstanding (EOP) too high?
Dabomb Protein Biotech's current Shares Outstanding (EOP) is 71.9 Mil. Overall, Dabomb Protein Biotech has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Shares Outstanding (EOP) compare to KHC and GIS?
Dabomb Protein Biotech's Shares Outstanding (EOP) of 71.9 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Consumer Packaged Goods company?
A good Shares Outstanding (EOP) depends on the Consumer Packaged Goods industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Dabomb Protein Biotech and its competitors. Dabomb Protein Biotech's current Shares Outstanding (EOP) is 71.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.52, compared to a current price of NT$16.40 — trading 12.9% above its estimated fair value. The current Shares Outstanding (EOP) is 71.9 Mil. Dabomb Protein Biotech's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Shares Outstanding (EOP) is 71.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?

Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued. The current stock price of NT$16.40 is trading 12.9% above its estimated GF Value™ of NT$14.52. GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.

Key valuation signals for ROCO:6578:

  • Shares Outstanding (EOP): 71.9 Mil
  • GF Value™: NT$14.52 vs. price of NT$16.40 (12.9% above fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dabomb Protein Biotech Business Description

Address No. 52, Industrial 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
59GF Score

Get the complete analysis for ROCO:6578

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.40
Price
NT$14.52
GF Value